Cargando…
Imaging α(v)β(3) integrin expression in skeletal metastases with (99m)Tc-maraciclatide single-photon emission computed tomography: detection and therapy response assessment
PURPOSE: Osteoclast activity is an important factor in the pathogenesis of skeletal metastases and is a potential therapeutic target. This study aimed to determine if selective uptake of (99m)Tc-maraciclatide, a radiopharmaceutical targeting α(v)β(3) integrin, occurs in prostate cancer (PCa) bone me...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915496/ https://www.ncbi.nlm.nih.gov/pubmed/29396636 http://dx.doi.org/10.1007/s00259-017-3926-7 |
_version_ | 1783316873749725184 |
---|---|
author | Cook, Gary J. R. Azad, Gurdip K. Taylor, Benjamin P. Lee, Eugene Morrison, Matthew S. Hughes, Simon Morris, Stephen Rudman, Sarah Chowdhury, Simon Goh, Vicky |
author_facet | Cook, Gary J. R. Azad, Gurdip K. Taylor, Benjamin P. Lee, Eugene Morrison, Matthew S. Hughes, Simon Morris, Stephen Rudman, Sarah Chowdhury, Simon Goh, Vicky |
author_sort | Cook, Gary J. R. |
collection | PubMed |
description | PURPOSE: Osteoclast activity is an important factor in the pathogenesis of skeletal metastases and is a potential therapeutic target. This study aimed to determine if selective uptake of (99m)Tc-maraciclatide, a radiopharmaceutical targeting α(v)β(3) integrin, occurs in prostate cancer (PCa) bone metastases and to observe the changes following systemic therapy. METHODS: The study group comprised 17 men with bone-predominant metastatic PCa who underwent whole-body planar and single-photon emission computed tomography/computed tomography (SPECT/CT) imaging with (99m)Tc-maraciclatide before (n = 17) and 12 weeks after (n = 11) starting treatment with abiraterone. Tumour to normal bone (T:N) ratios, tumour to muscle (T:M) ratios and CT Hounsfield units (HU) were measured in up to five target metastases in each subject. An oncologist blinded to study scans assessed clinical responses up to 24 weeks using conventional criteria. RESULTS: Before treatment, metastases showed specific (99m)Tc-maraciclatide accumulation (mean planar T:N and T:M ratios 1.43 and 3.06; SPECT T:N and T:M ratios 3.1 and 5.19, respectively). Baseline sclerotic lesions (389–740 HU) showed lower T:M ratios (4.22 vs. 7.04, p = 0.02) than less sclerotic/lytic lesions (46–381 HU). Patients with progressive disease (PD; n = 5) showed increased planar T:N and T:M ratios (0.29 and 12.1%, respectively) and SPECT T:N and T:M ratios (11.9 and 20.2%, respectively). Patients without progression showed decreased planar T:N and T:M ratios (0.27 and −8.0%, p = 1.0 and 0.044, respectively) and SPECT T:N and T:M ratios (−21.9, and −27.2%, p = 0.3 and 0.036, respectively). The percentage change in CT HU was inversely correlated with the percentage change in SPECT T:M ratios (r = −0.59, p = 0.006). CONCLUSIONS: (99m)Tc-maraciclatide accumulates in PCa bone metastases in keeping with increased α(v)β(3) integrin expression. Greater activity in metastases with lower CT density suggests that uptake is related to osteoclast activity. Changes in planar and SPECT T:M ratios after 12 weeks of treatment differed between patients with and without PD and (99m)Tc-maraciclatide imaging may be a potential method for assessing early response. |
format | Online Article Text |
id | pubmed-5915496 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-59154962018-04-30 Imaging α(v)β(3) integrin expression in skeletal metastases with (99m)Tc-maraciclatide single-photon emission computed tomography: detection and therapy response assessment Cook, Gary J. R. Azad, Gurdip K. Taylor, Benjamin P. Lee, Eugene Morrison, Matthew S. Hughes, Simon Morris, Stephen Rudman, Sarah Chowdhury, Simon Goh, Vicky Eur J Nucl Med Mol Imaging Original Article PURPOSE: Osteoclast activity is an important factor in the pathogenesis of skeletal metastases and is a potential therapeutic target. This study aimed to determine if selective uptake of (99m)Tc-maraciclatide, a radiopharmaceutical targeting α(v)β(3) integrin, occurs in prostate cancer (PCa) bone metastases and to observe the changes following systemic therapy. METHODS: The study group comprised 17 men with bone-predominant metastatic PCa who underwent whole-body planar and single-photon emission computed tomography/computed tomography (SPECT/CT) imaging with (99m)Tc-maraciclatide before (n = 17) and 12 weeks after (n = 11) starting treatment with abiraterone. Tumour to normal bone (T:N) ratios, tumour to muscle (T:M) ratios and CT Hounsfield units (HU) were measured in up to five target metastases in each subject. An oncologist blinded to study scans assessed clinical responses up to 24 weeks using conventional criteria. RESULTS: Before treatment, metastases showed specific (99m)Tc-maraciclatide accumulation (mean planar T:N and T:M ratios 1.43 and 3.06; SPECT T:N and T:M ratios 3.1 and 5.19, respectively). Baseline sclerotic lesions (389–740 HU) showed lower T:M ratios (4.22 vs. 7.04, p = 0.02) than less sclerotic/lytic lesions (46–381 HU). Patients with progressive disease (PD; n = 5) showed increased planar T:N and T:M ratios (0.29 and 12.1%, respectively) and SPECT T:N and T:M ratios (11.9 and 20.2%, respectively). Patients without progression showed decreased planar T:N and T:M ratios (0.27 and −8.0%, p = 1.0 and 0.044, respectively) and SPECT T:N and T:M ratios (−21.9, and −27.2%, p = 0.3 and 0.036, respectively). The percentage change in CT HU was inversely correlated with the percentage change in SPECT T:M ratios (r = −0.59, p = 0.006). CONCLUSIONS: (99m)Tc-maraciclatide accumulates in PCa bone metastases in keeping with increased α(v)β(3) integrin expression. Greater activity in metastases with lower CT density suggests that uptake is related to osteoclast activity. Changes in planar and SPECT T:M ratios after 12 weeks of treatment differed between patients with and without PD and (99m)Tc-maraciclatide imaging may be a potential method for assessing early response. Springer Berlin Heidelberg 2018-02-02 2018 /pmc/articles/PMC5915496/ /pubmed/29396636 http://dx.doi.org/10.1007/s00259-017-3926-7 Text en © The Author(s) 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Article Cook, Gary J. R. Azad, Gurdip K. Taylor, Benjamin P. Lee, Eugene Morrison, Matthew S. Hughes, Simon Morris, Stephen Rudman, Sarah Chowdhury, Simon Goh, Vicky Imaging α(v)β(3) integrin expression in skeletal metastases with (99m)Tc-maraciclatide single-photon emission computed tomography: detection and therapy response assessment |
title | Imaging α(v)β(3) integrin expression in skeletal metastases with (99m)Tc-maraciclatide single-photon emission computed tomography: detection and therapy response assessment |
title_full | Imaging α(v)β(3) integrin expression in skeletal metastases with (99m)Tc-maraciclatide single-photon emission computed tomography: detection and therapy response assessment |
title_fullStr | Imaging α(v)β(3) integrin expression in skeletal metastases with (99m)Tc-maraciclatide single-photon emission computed tomography: detection and therapy response assessment |
title_full_unstemmed | Imaging α(v)β(3) integrin expression in skeletal metastases with (99m)Tc-maraciclatide single-photon emission computed tomography: detection and therapy response assessment |
title_short | Imaging α(v)β(3) integrin expression in skeletal metastases with (99m)Tc-maraciclatide single-photon emission computed tomography: detection and therapy response assessment |
title_sort | imaging α(v)β(3) integrin expression in skeletal metastases with (99m)tc-maraciclatide single-photon emission computed tomography: detection and therapy response assessment |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915496/ https://www.ncbi.nlm.nih.gov/pubmed/29396636 http://dx.doi.org/10.1007/s00259-017-3926-7 |
work_keys_str_mv | AT cookgaryjr imagingavb3integrinexpressioninskeletalmetastaseswith99mtcmaraciclatidesinglephotonemissioncomputedtomographydetectionandtherapyresponseassessment AT azadgurdipk imagingavb3integrinexpressioninskeletalmetastaseswith99mtcmaraciclatidesinglephotonemissioncomputedtomographydetectionandtherapyresponseassessment AT taylorbenjaminp imagingavb3integrinexpressioninskeletalmetastaseswith99mtcmaraciclatidesinglephotonemissioncomputedtomographydetectionandtherapyresponseassessment AT leeeugene imagingavb3integrinexpressioninskeletalmetastaseswith99mtcmaraciclatidesinglephotonemissioncomputedtomographydetectionandtherapyresponseassessment AT morrisonmatthews imagingavb3integrinexpressioninskeletalmetastaseswith99mtcmaraciclatidesinglephotonemissioncomputedtomographydetectionandtherapyresponseassessment AT hughessimon imagingavb3integrinexpressioninskeletalmetastaseswith99mtcmaraciclatidesinglephotonemissioncomputedtomographydetectionandtherapyresponseassessment AT morrisstephen imagingavb3integrinexpressioninskeletalmetastaseswith99mtcmaraciclatidesinglephotonemissioncomputedtomographydetectionandtherapyresponseassessment AT rudmansarah imagingavb3integrinexpressioninskeletalmetastaseswith99mtcmaraciclatidesinglephotonemissioncomputedtomographydetectionandtherapyresponseassessment AT chowdhurysimon imagingavb3integrinexpressioninskeletalmetastaseswith99mtcmaraciclatidesinglephotonemissioncomputedtomographydetectionandtherapyresponseassessment AT gohvicky imagingavb3integrinexpressioninskeletalmetastaseswith99mtcmaraciclatidesinglephotonemissioncomputedtomographydetectionandtherapyresponseassessment |